Blueprints for ATP machinery will aid tuberculosis drug design

-


Nature, Published online: 03 July 2024; doi:10.1038/d41586-024-02094-1

Structural insights into how anti-tuberculosis drugs interact with the enzyme that makes ATP in bacteria and humans pave the way for improved drug design to treat the disease and combat antimicrobial resistance.



Source link

Latest news

This Jammer Wants to Block Always-Listening AI Wearables. It Probably Won’t Work

Deveillance also claims the Spectre can find nearby microphones by detecting radio frequencies (RF), but critics say finding...

Marley Spoon Meal Kits Are Now More International and Easier to Make. Is That a Good Thing?

This included a Persian turmeric chicken with dill-currant rice that fits seamlessly into Marley Spoon's repertoire, deglazing with...

The Future of Iran’s Internet Is More Uncertain Than Ever

For more than six days, almost 90 million Iranians have been living under a total internet blackout. The...

These Beats Headphones We Like Are $150 Off

On the hunt for a fresh pair of headphones that stand out in the style department? Until the...

When AI Companies Go to War, Safety Gets Left Behind

I’ve spent the past few days asking AI companies to convince me that the prospects for AI safety...

Utexo Raises $7.5M To Launch Bitcoin-Native USDT Settlement Infrastructure

Utexo, a startup building Bitcoin-native stablecoin settlement infrastructure, announced a $7.5 million seed round co-led by...

Must read

You might also likeRELATED
Recommended to you